Mölnlycke plans to present new evidence to benefit caregivers and patients at this year’s AORN, which will be held at Morial Convention Center, in New Orleans, March 24-28. Focused on reduction of Surgical Site Infections (SSI) on C-Sections, two new studies support an up to 10-fold reduction in SSIs through utilization of Mepilex Border Post-Op antimicrobial dressings as part of surgical protocol. Mölnlycke will make this evidence and related materials available in their exhibit at Booth 1623.
Mölnlycke will also showcase Mepilex Border Sacrum and Heel and Z-Flo Fluidized positioners for Pressure Ulcer Prevention, in addition to its line up of prevention to post-acute solutions.
“Continued caregiver and patient understanding is important to us and central to what we call having ‘Customer at Heart’. Combined with our gained expertise and advanced technologies, we’ve developed a portfolio of SSI bundle solutions for perioperative care. Mölnlycke truly believes that together we can make a difference. Everyone involved – the patient, health care provider, the care facility and our health care system overall – benefits when we are able to work together to reduce infection rates,” says Al Concemi, vice president surgical marketing.
